ClinicalTrials.Veeva

Menu

Impact of Positive End-expiratory Pressure on Hepatic Venous Flow

K

Konkuk University Medical Center

Status

Unknown

Conditions

Valvular Heart Disease

Treatments

Procedure: low PEEP protective ventilation
Procedure: moderate PEEP protective ventilation
Procedure: low PEEP conventional ventilation
Procedure: moderate PEEP conventional ventilation

Study type

Interventional

Funder types

Other

Identifiers

NCT02700581
KUH000000 TBD

Details and patient eligibility

About

The purpose of this study is to determine the difference in the impact of moderate positive end-expiratory pressure (PEEP) on hepatic venous flow Doppler in patients undergoing cardiac surgery: conventional versus protective ventilation strategy The possible changes in forward and backward flows (Doppler profiles) of hepatic venous flow at different degrees of PEEP in conventional and protective ventilation strategies are analyzed by using intraoperative transesophageal echocardiography (TEE) in patients undergoing cardiac surgery .

Full description

Following data would be determined after 5 min-exposure volume controlled ventilation employing tidal volume of 10 ml/kg and 6 ml/kg with low PEEP (with 2 mmHg) and moderate PEEP (7 mmHg) during remifentanil-based anesthesia (1.0 mcg/kg/min) for cardiac surgery (n=12)

  1. sum of forward hepatic venous flow
  2. sum of backward hepatic venous flow
  3. peak velocity of diastolic hepatic venous flow
  4. lung compliance
  5. peak airway pressure
  6. mean airway pressure
  7. other pressure derived hemodynamic parameters:heart rate; systolic, diastolic, and mean blood pressures; systolic, diastolic, and mean pulmonary artery pressures; central venous pressure (CVP), pulmonary capillary

Enrollment

15 estimated patients

Sex

All

Ages

19 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing cardiac surgery
  • Patients provide written informed consents

Exclusion criteria

  • Re-do or tri-do surgery
  • Patients with active infection
  • Patients with endocrine disease
  • Patients ischemic heart disease
  • patients with tricuspid valve regurgitation greater than mild degree

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

15 participants in 4 patient groups

low PEEP conventional ventilation
Active Comparator group
Description:
PEEP 2 mmHg tidal volume 10ml/kg
Treatment:
Procedure: low PEEP conventional ventilation
moderate PEEP conventional ventilation
Experimental group
Description:
PEEP 7 mmHg tidal volume 10ml/kg
Treatment:
Procedure: moderate PEEP conventional ventilation
low PEEP protective ventilation
Experimental group
Description:
PEEP 2 mmHg with tidal volume 6 ml/kg
Treatment:
Procedure: low PEEP protective ventilation
moderate PEEP protective ventilation
Experimental group
Description:
PEEP 7 mmHg tidal volume 6ml/kg
Treatment:
Procedure: moderate PEEP protective ventilation

Trial contacts and locations

0

Loading...

Central trial contact

Tae-Yop Kim, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems